首次肺栓塞后的功能与运动受限:ELOPE前瞻性队列研究结果
ELOPE前瞻性队列研究在5家加拿大医院纳入100例急性肺栓塞患者,于1个月和12个月进行心肺运动试验(CPET)。预设主要终点为1年CPET时峰值摄氧量(Vo2 peak)占预计值<80%。1年时86例中40例(46.5%)达到主要终点,且与更差的通用健康相关生活质量、肺栓塞特异性生活质量和呼吸困难评分以及更短的6分钟步行距离(6MWD)显著相关。预测因素包括男性、年龄、BMI、吸烟史、1个月时Vo2 peak占预计值<80%以及1个月时6MWD。基线或残余血栓负荷与主要终点无关。作者认为急性肺栓塞后的去适应可能 underlying 这种运动受限,但不能排除肺栓塞前已存在。
要点
- 1年时46.5%(40/86)的肺栓塞患者CPET显示Vo2 peak占预计值<80%,存在运动受限。
- 运动受限与1年时通用健康相关生活质量、肺栓塞特异性生活质量及呼吸困难评分显著更差以及6MWD显著缩短相关。
- 男性(RR 3.2;95%CI 1.3-8.1)、年龄(每增加1岁RR 0.98;95%CI 0.96-0.99)、BMI(每增加1 kg/m2 RR 1.1;95%CI 1.01-1.2)、吸烟史(RR 1.8;95%CI 1.1-2.9)是主要终点的预测因素。
- 1个月时Vo2 peak占预计值<80%(RR 3.8;95%CI 1.9-7.2)和1个月时6MWD(每增加30 m RR 0.82;95%CI 0.7-0.9)可预测1年运动受限。
- 基线或残余血栓负荷与主要终点无关;1年时肺功能测试和超声心动图结果(肺动脉压力、左右心室收缩功能)在有和无运动受限的患者中均在正常范围内。
适用人群与场景
- 2010年至2013年在5家加拿大医院招募的100例急性肺栓塞患者。
诊断标准与关键阈值
- 预设主要终点为1年CPET时Vo2 peak占预计值<80%。
研究设计与关键结果
- 研究类型为前瞻性队列研究,纳入100例急性肺栓塞患者,在1个月和12个月进行CPET。
- 1年时86例中40例(46.5%)Vo2 peak占预计值<80%,与显著更差的通用健康相关生活质量、肺栓塞特异性生活质量和呼吸困难评分以及显著缩短的6MWD相关。
- 主要终点的预测因素:男性(RR 3.2;95%CI 1.3-8.1)、年龄(每增加1岁RR 0.98;95%CI 0.96-0.99)、BMI(每增加1 kg/m2 RR 1.1;95%CI 1.01-1.2)、吸烟史(RR 1.8;95%CI 1.1-2.9)、1个月时Vo2 peak占预计值<80%(RR 3.8;95%CI 1.9-7.2)、1个月时6MWD(每增加30 m RR 0.82;95%CI 0.7-0.9)。
- 基线或残余血栓负荷与主要终点无关。
- 1年时肺功能测试和超声心动图结果(肺动脉压力、左右心室收缩功能)在有和无运动受限的患者中均在正常范围内。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:作者指出不能排除运动受限在肺栓塞前已存在。
对床旁实践的改变
- 作者认为,1个月时CPET或6MWD测试可能有助于识别肺栓塞后1年运动受限高风险患者。
- 作者认为,急性肺栓塞后发生的去适应可能 underlying 这种运动受限,但不能排除肺栓塞前已存在。
指南或共识出处
- ELOPE Prospective Cohort Study;ClinicalTrials.gov注册号NCT01174628。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: We aimed to determine the frequency and predictors of exercise limitation after pulmonary embolism (PE) and to assess its association with health-related quality of life (HRQoL) and dyspnea.
METHODS: One hundred patients with acute PE were recruited at five Canadian hospitals from 2010 to 2013. Cardiopulmonary exercise testing (CPET) was performed at 1 and 12 months. Quality of life (QoL), dyspnea, 6-min walk distance (6MWD), residual clot burden (perfusion scan, CT pulmonary angiography), cardiac function (echocardiography), and pulmonary function tests (PFTs) were measured during follow-up. The prespecified primary outcome was percent predicted peak oxygen uptake (Vo2 peak) < 80% at 1-year CPET.
RESULTS: At 1 year, 40 of 86 patients (46.5%) had percent predicted Vo2 peak < 80% on CPET, which was associated with significantly worse generic health-related QoL (HRQoL), PE-specific HRQoL and dyspnea scores, and significantly reduced 6MWD at 1 year. Predictors of the primary outcome included male sex (relative risk [RR], 3.2; 95% CI, 1.3-8.1), age (RR, 0.98; 95% CI, 0.96-0.99 per 1-year age increase), BMI (RR 1.1; 95% CI, 1.01-1.2 per 1 kg/m2 BMI increase), and smoking history (RR, 1.8; 95% CI, 1.1-2.9), as well as percent predicted Vo2 peak < 80% on CPET at 1 month (RR, 3.8; 95% CI,1.9-7.2), and 6MWD at 1 month (RR, 0.82; 95% CI, 0.7-0.9 per 30-m increased walking distance). Baseline or residual clot burden was not associated with the primary outcome. Mean PFT and echocardiographic results (pulmonary artery pressure, right and left ventricular systolic function) at 1 year were similarly within normal limits in both patients with exercise limitations and those without such limitations.
CONCLUSIONS: Almost half of patients with PE have exercise limitation at 1 year that adversely influences HRQoL, dyspnea, and walking distance. CPET or 6MWD testing at 1 month may help to identify patients with a higher risk of exercise limitation at 1 year after PE. Based on our results, we believe that the deconditioning that occurs after acute PE could underlie this exercise limitation, but we cannot exclude the fact that this may have been present before PE.
TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT01174628; URL: www.clinicaltrials.gov.
参考来源
- Kahn SR, Hirsch AM, Akaberi A, et al. Functional and Exercise Limitations After a First Episode of Pulmonary Embolism: Results of the ELOPE Prospective Cohort Study. Chest. 2016. PMID: 27932051. doi:10.1016/j.chest.2016.11.030
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。